C

China National Medicines Corp Ltd
SSE:600511

Watchlist Manager
China National Medicines Corp Ltd
SSE:600511
Watchlist
Price: 34.38 CNY -0.12% Market Closed
Market Cap: 25.9B CNY
Have any thoughts about
China National Medicines Corp Ltd?
Write Note

China National Medicines Corp Ltd
PP&E Gross

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

China National Medicines Corp Ltd
PP&E Gross Peer Comparison

Comparables:
1099
601607
600998
000963
Q
301015

Competitive PP&E Gross Analysis
Latest Figures & CAGR of Competitors

Company PP&E Gross CAGR 3Y CAGR 5Y CAGR 10Y
C
China National Medicines Corp Ltd
SSE:600511
PP&E Gross
ÂĄ913.4m
CAGR 3-Years
2%
CAGR 5-Years
3%
CAGR 10-Years
7%
Sinopharm Group Co Ltd
HKEX:1099
PP&E Gross
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
PP&E Gross
ÂĄ18.3B
CAGR 3-Years
7%
CAGR 5-Years
8%
CAGR 10-Years
14%
Jointown Pharmaceutical Group Co Ltd
SSE:600998
PP&E Gross
ÂĄ9.1B
CAGR 3-Years
4%
CAGR 5-Years
5%
CAGR 10-Years
13%
Huadong Medicine Co Ltd
SZSE:000963
PP&E Gross
ÂĄ5.4B
CAGR 3-Years
3%
CAGR 5-Years
9%
CAGR 10-Years
15%
Q
Qingdao Baheal Medical Inc
SZSE:301015
PP&E Gross
ÂĄ395.3m
CAGR 3-Years
32%
CAGR 5-Years
17%
CAGR 10-Years
N/A

See Also

What is China National Medicines Corp Ltd's PP&E Gross?
PP&E Gross
913.4m CNY

Based on the financial report for Jun 30, 2024, China National Medicines Corp Ltd's PP&E Gross amounts to 913.4m CNY.

What is China National Medicines Corp Ltd's PP&E Gross growth rate?
PP&E Gross CAGR 10Y
7%

Over the last year, the PP&E Gross growth was 13%. The average annual PP&E Gross growth rates for China National Medicines Corp Ltd have been 2% over the past three years , 3% over the past five years , and 7% over the past ten years .

Back to Top